Global 5-Fluoro-2′-deoxyuridine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global 5-Fluoro-2′-deoxyuridine Market Research Report 2024
5-Fluoro-2′-deoxyuridine elicits DNA-directed cytotoxicity in cancer cells.
According to Mr Accuracy reports’s new survey, global 5-Fluoro-2′-deoxyuridine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole 5-Fluoro-2′-deoxyuridine market research.
Key manufacturers engaged in the 5-Fluoro-2′-deoxyuridine industry include Roche, DSM Nutritional, Taiho, Hikma Pharmaceuticals, Bedford Pharmaceuticals, Fresenius Kabi, Zibo Wanjie Pharmaceutical, Ningbo Tianheng Pharmaceutical and Jiangsu Shengdi Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of 5-Fluoro-2′-deoxyuridine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole 5-Fluoro-2′-deoxyuridine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 5-Fluoro-2′-deoxyuridine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Roche
DSM Nutritional
Taiho
Hikma Pharmaceuticals
Bedford Pharmaceuticals
Fresenius Kabi
Zibo Wanjie Pharmaceutical
Ningbo Tianheng Pharmaceutical
Jiangsu Shengdi Pharmaceutical
Qilu Pharmaceutical
Zhejiang Guobang Pharmaceutical
Zhejiang Hisun Pharmaceutical
Yangzijiang Pharmaceutical
Segment by Type
10mg
25mg
100mg
250mg
500mg
Rectal Cancer
Liver Cancer
Breast Cancer
Lung Cancer
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The 5-Fluoro-2′-deoxyuridine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global 5-Fluoro-2′-deoxyuridine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole 5-Fluoro-2′-deoxyuridine market research.
Key manufacturers engaged in the 5-Fluoro-2′-deoxyuridine industry include Roche, DSM Nutritional, Taiho, Hikma Pharmaceuticals, Bedford Pharmaceuticals, Fresenius Kabi, Zibo Wanjie Pharmaceutical, Ningbo Tianheng Pharmaceutical and Jiangsu Shengdi Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of 5-Fluoro-2′-deoxyuridine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole 5-Fluoro-2′-deoxyuridine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 5-Fluoro-2′-deoxyuridine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
DSM Nutritional
Taiho
Hikma Pharmaceuticals
Bedford Pharmaceuticals
Fresenius Kabi
Zibo Wanjie Pharmaceutical
Ningbo Tianheng Pharmaceutical
Jiangsu Shengdi Pharmaceutical
Qilu Pharmaceutical
Zhejiang Guobang Pharmaceutical
Zhejiang Hisun Pharmaceutical
Yangzijiang Pharmaceutical
Segment by Type
10mg
25mg
100mg
250mg
500mg
Segment by Application
Rectal Cancer
Liver Cancer
Breast Cancer
Lung Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The 5-Fluoro-2′-deoxyuridine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source